Development and physico-mechanical characterisation of lyophilised chitosan wafers as potential protein drug delivery systems via the buccal mucosa

被引:84
作者
Ayensu, Isaac [1 ,2 ]
Mitchell, John C. [1 ]
Boateng, Joshua S. [1 ]
机构
[1] Univ Greenwich Medway, Sch Sci, Dept Pharmaceut Chem & Environm Sci, Chatham ME4 4TB, Kent, England
[2] Kwame Nkrumah Univ Sci & Technol, Fac Pharm & Pharmaceut Sci, Dept Pharmaceut Chem, Kumasi, Ghana
关键词
Chitosan; Lyophilised wafers; Mucoadhesion; Buccal delivery; Protein; PRIMARY DRYING RATE; THIOLATED CHITOSANS; FILMS; PLATFORMS; RELEASE;
D O I
10.1016/j.colsurfb.2011.11.004
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
Lyophilised wafers from chitosan have been developed as potential protein drug delivery systems via the buccal mucosa. Wafers were prepared by lyophilising aqueous gels of the polymer incorporating varying concentrations of glycerol as plasticizer and D-mannitol as cryoprotectant. The different formulations were characterised by their physico-mechanical properties in order to select the optimum system for further development. The optimised formulation with 6.5 mg each of both plasticizer and cryoprotectant was loaded with bovine serum albumin and lyophilised with or without annealing. Differential scanning calorimetry was used to determine the appropriate lyophilisation cycle by evaluating thermal events before lyophilisation and possible phase separation of bovine serum albumin after lyophilisation. Texture analysis was employed to investigate the in vitro mucoadhesive properties in tensile mode, residual moisture content by thermo-gravimetric analysis while hydration capacity and drug release studies were performed in 0.1 M phosphate buffered saline. Microscopic architecture and crystallinity were examined using scanning electron microscopy and X-ray diffractometry respectively. The ease of hydration, in vitro mucoadhesive characteristics, microscopic architecture and BSA release were influenced by the annealing process. A 7 h cumulative percentage drug release of 91.5% and 80.1% was observed for the annealed and non-annealed wafers respectively. The results showed the potential of employing lyophilised chitosan wafers for buccal mucosa delivery of protein based drugs. (C) 2011 Elsevier B.V. All rights reserved.
引用
收藏
页码:258 / 265
页数:8
相关论文
共 33 条
[1]   Chitosan-based delivery systems for protein therapeutics and antigens [J].
Amidi, Maryam ;
Mastrobattista, Enrico ;
Jiskoot, Wim ;
Hennink, Wim E. .
ADVANCED DRUG DELIVERY REVIEWS, 2010, 62 (01) :59-82
[2]   Characterisation of freeze-dried wafers and solvent evaporated films as potential drug delivery systems to mucosal surfaces [J].
Boateng, Joshua S. ;
Auffret, Anthony D. ;
Matthews, Kerr H. ;
Humphrey, Michael J. ;
Stevens, Howard N. E. ;
Eccleston, Gillian M. .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2010, 389 (1-2) :24-31
[3]   Development and mechanical characterization of solvent-cast polymeric films as potential drug delivery systems to mucosal surfaces [J].
Boateng, Joshua S. ;
Stevens, Howard N. E. ;
Eccleston, Gillian M. ;
Auffret, Anthony D. ;
Humphrey, Michael J. ;
Matthews, Kerr H. .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2009, 35 (08) :986-996
[4]  
Bunte H, 2010, PHARM TECHNOL EUR DI, V22, P2
[5]   Hydrogen bonding and the cryoprotective properties of glycerol/water mixtures [J].
Dashnau, Jennifer L. ;
Nucci, Nathaniel V. ;
Sharp, Kim A. ;
Vanderkooi, Jane M. .
JOURNAL OF PHYSICAL CHEMISTRY B, 2006, 110 (27) :13670-13677
[6]   Investigations on the lyophilisation of MPEG-hexPLA micelle based pharmaceutical formulations [J].
Di Tommaso, Claudia ;
Como, Caterina ;
Gurny, Robert ;
Moeller, Michael .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2010, 40 (01) :38-47
[7]  
Ernst Orna, 2010, J Vis Exp, DOI 10.3791/1918
[8]   Polysaccharide colloidal particles as delivery systems for macromolecules [J].
Janes, KA ;
Calvo, P ;
Alonso, MJ .
ADVANCED DRUG DELIVERY REVIEWS, 2001, 47 (01) :83-97
[9]  
Jiang Ge, 2007, PDA J Pharm Sci Technol, V61, P441
[10]   Rheological and mucoadhesive characterization of polymeric systems composed of poly(methylvinylether-co-maleic anhydride) and poly(vinylpyrrolidone), designed as platforms for topical drug delivery [J].
Jones, DS ;
Lawlor, MS ;
Woolfson, AD .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2003, 92 (05) :995-1007